Adveritas Limited, specializing in digital marketing anti-fraud solutions with its product TrafficGuard, reported a record ARR of $12.2 million for the September 2025 quarter. The company has been actively expanding its affiliate and Meta commercial offerings, with several trials in progress and expected contract conversions in December. Despite a decreased cash receipt of $1.5 million due to the timing of prepaid renewals, Adveritas maintains a cash balance of $6.9 million, supporting its growth initiatives, including an expansion into the US market. Operating expenditures were kept at $3.8 million, with continued focus on global market share growth, AI strategy enhancement, and affiliate services expansion. The company's outlook remains strong as it leverages its innovative solutions to capture a larger share of the ad tech market.
Key Points
Adveritas Limited reported a record annualised recurring revenue (ARR) of $12.2 million for the September 2025 quarter.
The company signed several affiliate agreements subject to trial results, which are expected to finalize in December.
Meta commercialization efforts include 17 ongoing trials with expected contract conversions by December.
Operating expenditure for the quarter was approximately $3.8 million.
The company's cash balance stands at $6.9 million as of 30 September 2025.
Adveritas is expanding its operations in the US with significant progress in client trials and potential contracts worth approximately $750k.
TrafficGuard, the company's flagship product, continues to protect digital ad spend from fraud and optimize campaign performance.
The company aims to expand its affiliate service, potentially increasing revenue opportunities for existing and new clients.
The outlook for Adveritas involves further development in AI strategies, global market expansion, and continued product channel growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.